Report OverviewDue to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Photodynamic Therapy estimated at USD million in the year 2022, is projected to reach a revised size of USD million by 2028, growing at a CAGR of percent during the forecast period 2022-2028.The USA market for Photodynamic Therapy is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The China market for Photodynamic Therapy is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The Europe market for Photodynamic Therapy is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The global key companies of Photodynamic Therapy include Sanofi, DUSA Pharmaceuticals, Bausch Health, Beiersdorf, Soligenix, Theralase Technologies, Quest Pharmatech, Galderma and Biofrontera, etc. In 2021, the global top five players had a share approximately percent in terms of revenue.